Ingredion Incorporated heads into its May 20 earnings date with options traders suddenly far more defensive than they have been all year.
The sharpest signal this week is in the options market. The put/call ratio jumped to 0.671 on Tuesday — more than three standard deviations above its 20-day mean of 0.415. That is the most defensive options reading in months, and it appeared in a single session after the ratio had been running below 0.40 for most of April. The shift is stark: for most of the past month, call buyers dominated; now put demand has surged well ahead of the mid-May print.
Short interest paints a quieter picture, and the contrast matters. SI nudged up less than 2% over the week to roughly 4.1% of the free float — well off the early-April peak when shares outstanding on loan briefly approached twice their current level. The lending market remains loose: borrow availability is ample, and cost to borrow is still modest at 0.69%, even after jumping 35% in the past week from its prior range of 0.40–0.51%. That cost-to-borrow move is worth noting — it may reflect the same pre-earnings nerves visible in the options market — but with availability still comfortable, there is no squeeze dynamic building. The ORTEX short score has edged up to 41.4 from around 37 three weeks ago, but remains well within the middle of its range.
The Street has been steadily shaving targets without abandoning the bull thesis. Barclays trimmed to $120 from $128 just this week, maintaining an Equal-Weight. Oppenheimer cut to $126 from $130 in late April while holding its Outperform. UBS moved to $122 in early April, also flat on rating. The direction of travel is uniform — lower targets, unchanged ratings — which typically signals caution on near-term execution rather than a fundamental re-rating. The consensus mean now stands at $123, implying about 15% upside from the current price of $107.13. Valuation multiples give some support to the bull case: PE has compressed to around 9.5x over the past month, and EV/EBITDA is at 6.2x. The EV/EBIT factor score ranks in the 89th percentile of the universe — a number that signals the stock screens as cheap on an earnings-power basis relative to peers, even after the recent slide.
Insider activity over the past 90 days skews toward selling, but context is important. The largest single transaction was CEO James Zallie's sale of roughly 9,958 shares at $116.55 in February — a $1.16 million transaction — followed by smaller sales from the CFO and CCO around the same time. These look consistent with pre-planned sell programs rather than conviction-driven distribution, and the net 90-day figure of approximately 92,470 shares sold is modest relative to the institutional base. Vanguard holds 11.9% and BlackRock 9.7%, with the ownership base broadly stable. The more notable institutional move is First Trust Advisors, which added nearly 2 million shares in the period ending April 30 — a meaningful build for a name of this size.
Peer performance this week is mixed. CAG fell less than 2% on the week, GIS was essentially flat, and KHC was marginally positive — making INGR's 5.2% weekly decline look like an underperformer against its closest agricultural-consumer food peers. PPC dropped nearly 5%, so some of the sector softness is genuine, but INGR has clearly absorbed more pressure than the broader group.
The setup heading into May 20 is one where options hedging has spiked, analysts are cutting numbers on unchanged ratings, and the stock is near a 12-month low while screening cheaply on earnings multiples. Whether the print resolves that tension — or deepens it — is the question the next two weeks will answer.
See the live data behind this article on ORTEX.
Open INGR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
